Approval · Notice of Compliance 9889 · 2008
MYOZYME: Notice of Compliance 9889
Issued November 13, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9889
- Date
- November 13, 2008
- Company
- Genzyme Canada Inc
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph
- Therapeutic class
- Enzyme replacement therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MYOZYME | Not yet assigned | — |
Medicinal ingredients
- ALGLUCOSIDASE ALFA 50 MG per VIAL